ERBB4 and Neurodegeneration: Association Between Hypothalamic-Pituitary-Adrenal (HPA) Axis: Associated Neurodegenerative Pathogenesis. [PDF]
Bagyinszky E, An SSA.
europepmc +1 more source
Fatty acid synthase affects expression of ErbB receptors in epithelial to mesenchymal transition of breast cancer cells and invasive ductal carcinoma. [PDF]
Chen T +7 more
europepmc +1 more source
ErbB receptors and their growth factor ligands in pediatric intestinal inflammation. [PDF]
Frey MR, Brent Polk D.
europepmc +1 more source
Glyoxal induces arterial injury through the inactivation of receptors and signaling pathways. [PDF]
Xie MZ +13 more
europepmc +1 more source
Differential ErbB receptor dimerization modulates the ability of EGF receptor ligands to regulate metabolic flux. [PDF]
Macdonald-Obermann J +3 more
europepmc +1 more source
Combination treatment with intravesical interferon-alpha gene therapy and an oral pan-ErbB receptor family blocker improves survival in mice with bladder cancer. [PDF]
Sood A +13 more
europepmc +1 more source
Inactive ERBB receptors cooperate with reactive oxygen species to suppress cancer progression. [PDF]
Hart MR +4 more
europepmc +1 more source
Cutaneous gain-of-function mutation of LRIG3 leads to alopecia by upregulation of ERBB, PI3K/AKT, NOTCH1 signaling pathways. [PDF]
Ghorbanalipoor S +3 more
europepmc +1 more source
Molecular Mediators Associated With Myelination, Demyelination, and Remyelination in the Peripheral Nervous System. [PDF]
Hagen KM, Ousman SS.
europepmc +1 more source
Recognition of ErbB Family Dimers by the EGF-like Domain of NRG1alpha and Beta: Implications for Ligand-Based CAR Therapy. [PDF]
Novikov A +8 more
europepmc +1 more source

